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ABSTRACT 
Metal ions are important elements in biology and are involved in numerous reactions essential 
for maintaining life on earth. Most commonly, metal ions confer their role as structural elements 
or catalytic cofactors within metalloproteins. Metalloproteins comprise more than half of all 
known proteins and are at the heart of several important biological processes including 
photosynthesis, respiration, and nitrogen fixation. Another equally important role of metal ions is 
as signaling molecules. It has been shown that changes in concentrations of calcium, zinc, or 
copper can trigger downstream signaling effect in neurons. Despite these important functions, 
high levels of many metal ions, especially transition metal ions, are known to be toxic to cells. 
Thus, cells have adapted strategies to finely regulate the uptake, storage, and distribution of 
metal ions within different compartments. The importance of these mechanisms for maintaining 
metal ion homeostasis within cells and the key role of metal ions in life have been of major 
interest for years. However, the understanding of these mechanisms and how metal ions play 
their role is largely unknown in many cases. An important step towards advancing our 
understanding of metal ions is developing the ability to measure their concentrations in different 
cellular compartments with accuracy and sensitivity.  
To achieve this goal, several techniques are available that have greatly advanced our 
understanding of metal ions. However, current methods suffer from a number of limitations that 
have slowed progress. Analytical tools such as ICP-MS and AAS, while effective at measuring 
the cocnentrations of metal ions very sensitively, usually work in bulk and thus are not easily 
amenable to single cell studies let alone the distribution in different cellular compartments. 
Moreover, these techniques are often unable to distinguish between different oxidation states of a 
metal ion or between bound and mobile forms. Techniques based on X-ray absorption, such as 
X-ray fluorescence microscopy (XFM) can simultaneously detect multiple metal ions and can 
distinguish between different oxidation states. However, these techniques require the use of 
highly focused X-ray beams limiting more widespread availability of such techniques. 
Furthermore, biological samples cannot be examined in a real time manner, and the obtained 
distribution of metal ions represents only total metal content, without regard to whether the 
metals are easily exchangeable or are tightly bound, a major factor determining biological 
activity. 
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To overcome these issues several metal ion sensors have been designed based on either small 
molecules or proteins with great sensitivities of detection. The use of such sensors has provided 
great insight into the functions of metal ions. However, as these sensors are usually rationally 
designed through a trial and error process, it is challenging to generalize the successful designs to 
sense other metal ions or to meet new desired criteria. DNAzymes, DNA sequences with 
catalytic activity, have recently emerged as an alternative class of sensors for metal ions. As 
selection of DNAzymes for different metal ions is carried out through a combinatorial process, 
new sequences with desired activity and selectivity can be easily obtained by changing the 
selection conditions. Many DNAzymes have been selected with high sensitivity for different 
metal ions including zinc, copper, lead, and uranyl. Surprisingly, despite the promise of using 
DNAzymes as sensors for cellular metal ions, almost all applications of DNAzyme-based 
sensors until now have been in environmental metal ion detection and DNAzyme-based sensors 
for cellular metal detection have only very recently been explored as an option. 
The goal of my PhD research was to establish novel strategies to make DNAzymes viable 
sensors for cellular metal ion detection. Chapter 1 briefly describes the background and overall 
aims of my research. In chapter 2, I describe my efforts in designing “caged” DNAzyme-based 
sensors that can be activitated by light when they reach the desired cellular compartments. This 
method reduces the off-target signals and as demonstrated in this chapter is highly generalizable 
to other DNAzyme-based sensors. In chapter 3, I explain my efforts in designing a ratiometric 
DNAzyme-based sensor to enable quantitative measurement within the cells. Finally, chapter 4 
summarizes my efforts in enhancing the caging strategy to enable better stability, faster 
decaging, or the use of long-wavelength light for decaging by using lanthanide-doped metal 
nanoparticles. 
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Chapter 1: 
 
Introduction 
 
1.1 Metals in biology 
 
 Metal ions are essential elements in biology, playing critical roles in many important functions 
within cells. Most commonly, metal ions play their role as structural or catalytic cofactors within 
metalloproteins, where they assist in protein folding or enable catalytic reactivity not possible by amino 
acids alone.1 Metalloproteins comprise more than half of all known proteins2,3 and even more microbial 
metalloproteomes have yet to be explored.4 Many of these metalloproteins are involved in biochemical 
reactions essential to life, such as photosynthesis and respiration, that are only possible due to the added 
chemical functionality offered by these metal ions.1 As a result, cells must have methods for taking up 
sufficient concentrations of metal ions to ensure their availability for incorporation into metalloproteins.2 
At the same time, many metal ions, especially transition metals, are toxic when in excess. To balance the 
requirement for sufficient metal ion uptake with the need to avoid toxicity, cells have developed 
sophisticated mechanisms for regulation and storage of metal ions to control intracellular levels within a 
narrow range, even when extracellular levels of the metal may fluctuate widely.5,6 The importance of 
these mechanisms for maintaining the homeostasis of metal ions in cells has made them a subject of 
major interest.7-10 As a result, a great deal of effort has been employed to better elucidate them. 
 On par with their catalytic activity, metal ions play another essential function in life as intra- or inter-
cellular signaling agents. It has been identified that alterations in the levels of metals including calcium,11 
zinc,12 and copper13 can trigger downstream effects, which can be critical in the proper functioning of 
cells. The best-known example of such effects is the use of calcium (Ca2+) by excitable cells such as 
neurons, where the calcium ion is normally constitutively exported from the cell but is rapidly transported 
into the cell at the end of the action potential.11 The calcium ion then is recognized by intracellular 
calcium sensing proteins such as calmodulin and calpain, which control myriad pathways within the cell, 
before being re-exported to prime the cell for further activation.11,14,15 Another example is that of zinc 
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(Zn2+), which is found in extremely high levels in presynaptic vesicles of “gluzinergic” neurons in the 
hippocampus.16-19 Zinc from these neurons is released along with other neurotransmitters such as 
glutamine after activation of the neuron, whereupon the zinc is believed to function as a neuromodulator 
due to its ability to bind to and inhibit AMPA and NMDA receptors.17,20 Finally, copper (Cu2+) is also 
present in high levels in central nervous system where it plays a role in synaptic transmission through 
modulating the function of type A GABA receptor, NMDA, and voltage-gated calcium channels.13,21  
 It is important to note that a metal ion within a cell can perform several functions simultaneously 
without one function precluding others. Furthermore, beyond calcium, zinc, and copper, other metal ions 
are known to be necessary for life including iron, manganese, magnesium, and many others.22-26  
 Despite the important roles played by metal ions, our understanding of their functions varies 
significantly and is in some cases very limited. An important step in understanding the function of metal 
ions is measuring the levels of those ions, particularly within a cell. Thus, the development of appropriate 
tools for detection of intracellular metal ions has thus been a subject of major interest. 
 
1.2 Methods for metal ion detection in biological systems 
 
 There are many methods for the sensitive detection of metal ions. One method is to use analytical 
techniques including atomic absorption spectroscopy (AAS), flame absorption spectroscopy, inductively 
coupled plasma mass spectrometry (ICP-MS), and others.27 While these analytical techniques are 
extremely sensitive and very good at differentiating between different elements, they are not always 
capable of differentiating between ionic forms of the same element. This can be problematic as multiple 
oxidation states can play significantly different functions within a particular biological environment. 
Furthermore, these methods are typically bulk methods, which limits study of individual cells, and are 
difficult to use to distinguish between metals located in different cellular compartments or organelles. It is 
possible to use ultracentrifugation or other separation methods in order to physically separate and study a 
particular organelle prior to sample analysis,28 but such separation methods are extremely laborious and 
add extra steps that may confound accurate data collection. 
 Another major class of techniques is based on the use of X-rays, most often through X-ray 
fluorescence (XRF) microscopy methods. The physical basis underlying these techniques is the 
absorbance of X-rays by metal ions, which varies depending on element and oxidation state.29 As a result, 
these techniques are element- and even ion-specific. Using XRF, it is possible to obtain maps indicating 
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the distribution of oxidation states within a fixed cell.30,31 In these methods it is possible to measure 
multiple elements simultaneously, which is extremely helpful for correlative studies. This level of 
information is extremely valuable, but comes with some significant limitations. The first limitation is the 
need to use high-energy X-rays, which typically requires the use of a synchrotron. Another limitation is 
that biological samples used for these techniques must be frozen before use (and often fixed using organic 
solvent or polyaldehydes), meaning that the final image corresponds only to a single snapshot. Finally, 
with XRF, it is difficult to assess the ligand environment of the metal. Images obtained from XRF will 
indicate the total amount of a metal ion within the cell regardless of its ligand environment.29 This means 
that XRF alone may not be capable of distinguishing between a metal ion that is tightly bound (for 
instance, one within the active site of a metalloprotein) and a metal ion of the same oxidation state that is 
loosely bound by organic or inorganic ligands within the cell (such as nucleotides or polyphosphates);29-31 
from a biological standpoint, however, the difference between these two types of metal ions (strongly- or 
loosely-bound) is significant.12,13,30,32 This fact has led to the investigation of other methods capable of 
measuring not only the distribution of metal ions within the cell, but also able to distinguish between 
metal ions on the basis of biological accessibility (also termed lability).7-9,33 
 
1.3 Fluorescent metal ion sensors 
 
 In order to help understand the distribution of metal ions within cells, a number of cellular sensors 
have been developed, most commonly those based on small organic molecules or proteins.7-10 Of the 
available methods for real-time sensing in cells, fluorescent sensors have been the predominant choice 
due to their high signal intensity, fast response times, and ability to directly probe labile pools of metal 
ions.7-10 A number of examples and the corresponding metal ions probed are shown in Figure 1.1.10 While 
these sensors have greatly expanded our understanding of the biological role of metal ions, much still 
remains to be understood. One problem that has slowed the progress in understanding the role of metals 
in biology is the significant heterogeneity of conditions under which metal ions can be found, 
necessitating the development of a wide variety of sensors for different applications.10,34  
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Figure 1.1. Sensors used for studying cellular metal ions, and the corresponding metal ions detected. Originally from Ref. 10.10 
 
1.4 Rational design versus combinatorial selection 
 
 A major roadblock in the process of sensor design is that current paradigm of sensor design relies 
heavily on rational design for both small molecules and proteins. This process is essentially one of trial 
and error, in which success in creating one sensor for one metal ion may not generalize towards the 
creation of other sensors for the same or different metal ions. An alternative approach is combinatorial 
selection, for which the requirements to generate a sensor are different. In combinatorial selection the 
selection conditions are tuned to fit the desired final properties of the sensor and large quantities of 
chemical space are screened. As a result, it is not necessary to use the accumulated knowledge of 
potentially subtle differences in coordination preference and geometry for different metal ions in order to 
obtain appropriate sensors with desired selectivity and sensitivity.35,36  
 An excellent example of the power of combinatorial selection is in the production of antibodies, 
which is one of the most commonly utilized combinatorial selection techniques. Antibody selection takes 
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advantage of the natural variation performed by alternative splicing of antibody sequences in developing 
lymphocytes, in what is known as “VDJ recombination”.37,38 This process generates a wide variety of 
possible antibody sequences, which enables recognition of a huge range of possible targets by the immune 
system. The importance of this approach is evidenced by the ubiquity of antibody use in the biological 
sciences, and the huge and constantly growing catalog of commercially available antibodies for both 
research and therapeutic use.39,40 The method for producing specific antibodies for a particular antigen is 
simply to introduce the desired antigen into an animal at various times with a particular dosage schedule. 
If the animal is immunocompetent and the target appropriate for antibody recognition, the immune system 
produces memory cells that recognize the antigen and produce appropriate antibodies to bind it. After a 
series of injections of the antigen, it is then possible to inject the antigen at a later time-point, which 
induces production of antigen-specific antibodies. These can either be harvested directly from the blood,41 
or antibody-producing immune cells can be collected from the blood, screened, and used to create 
hybridomas for continuous production of monoclonal antibodies (Figure 1.2).42,43  
 
Figure 1.2. Diagram for hybridoma production of monoclonal antibodies. Originally from Ref. 44.44 
 
 A similar strategy to antibody selection is phage display, which is used to obtain recognition 
peptides (also called peptide aptamers).40,45,46 In the most common implementation of this method a 
library of peptides is affixed to the surface of the M13 bacteriophage by ligation of corresponding DNA 
sequences to one of the coat proteins of the bacteriophage.46 The phage particles produced are then 
introduced to a lawn of bacteria with the intended target attached to their surface, and only phages capable 
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of binding to and infecting bacteria are collected.45,46 Alternatively, the phages can be exposed to a 
surface coated with the target. Unbound phages are separated by simple washing, and bound phages can 
be eluted by the addition of excess ligands and amplified for the next round (Figure 1.3).45,46 This 
amplification method allows the production of small peptides capable of recognizing targets including 
proteins, peptides, nucleotides, and small molecules. 
  
Figure 1.3. Schematic representation of phage display technique for production of antibodies. Originally from Ref. 47.47 
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 While these methods are powerful and capable of producing recognition elements for a wide variety 
of targets, there are certain technical limitations shared by both these and similar methods that limit the 
scope of possible targets. For antibody selection, the method for selection requires injecting an animal and 
having the immune system recognize the target.41 There are several requirements for an appropriate 
antigen for this process. First, it must not be a component of the animal host. Targets that are highly 
conserved between species can be very difficult to address using such techniques.48 Many other targets 
such as oligonucleotides or common biological small molecules (e.g. ATP) that are used by all forms of 
life also cannot be targeted by antibodies as the immune system is designed to recognize those as self-
antigens. Finally, in order for an antigen to be presented to immune cells, it should not be smaller than a 
certain threshold. In particular, metal ions are far too small to be recognized by antibodies.49 To a limited 
extent, it is possible to carry out phage display methods to avoid some of these issues and produce peptide 
aptamers towards some targets not addressed by antibodies.45 However, phage display, while perhaps 
applicable to a wider range of targets, has additional technical issues. The first is that the peptide 
sequence itself must be attached to the phage without compromising phage capsid formation, which can 
be challenging for proteins and very large peptides. The second major issue is the need to immobilize the 
target onto a surface. Metal ions in particular are difficult to immobilize in such a fashion that they are 
still recognizable by peptides, as their extremely small size hinders immobilization methods. Chelation of 
metal ions is the only effective method to immobilize a metal ion, but necessarily hinders the selective 
binding of any alternative ligand, such as the peptide aptamer.50 This means that the ability to effectively 
immobilize the metal ion is in direct competition with the ability of the combinatorially selected ligand to 
recognize the metal ion itself. 
 
1.5 DNAzymes, a potential scaffold 
 
 An alternative type of sensor that has shown some promise of addressing the challenges of sensor 
production is based on a catalytic DNA scaffold.51,52 DNAzymes are sequences of DNA whose sequence 
defines a three-dimensional structure that can carry out catalytic activity. First discovered in 1994, 
DNAzymes have been shown to carry out a wide range of reactivity from RNA hydrolysis to porphyrin 
metallation to Diels-Alder catalysis.53 In the majority of the cases, these DNAzymes use specific metal 
ion cofactors in order to carry out reactivity, but the metal ions necessary can vary depending on the 
sequence.  
	   8	  
 Previously, methods have been developed for obtaining DNAzymes with altered cofactor specificity 
for the same catalytic reaction - RNA cleavage (transesterification).36 Using a combinatorial process 
called systematic evolution of ligands by exponential enrichment (SELEX) or simply in vitro 
selection,35,36 massive random pools of DNA (up to 1015 different sequences) can be screened in a 
straightforward fashion (Figure 1.4). This process does not require immobilization of the metal ion, 
instead relying on observation of the RNA cleavage process to measure metal binding and activity. By 
carefully defining conditions for activity and control conditions for negative selection, DNAzymes with 
specific binding affinity, selectivity, and sensitivity have been obtained, for a variety of metal ions 
including Zn2+, Pb2+, Cu2+, UO22+, Mg2+ and Hg2+.51,52  
 
Figure 1.4. General strategy for in vitro selection of metal ion-specific DNAzymes. Each cycle results in a random pool more 
enriched in sequences active for the target of interest. 
 
 A further development was the recognition that the similarity in catalytic function between these 
DNAzyme sequences would allow a single reporter strategy to convert all DNAzymes with the same type 
of reactivity into sensors (Figure 1.5.a).51,52,54 This so-called “catalytic beacon” approach allowed the 
generation of DNAzyme-based metal ion sensors from the corresponding DNAzymes. In this construct 
the cleaved substrate will dissociate from the enzyme-substrate complex due to its lower melting 
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temperature of Watson-Crick base pairing compared to an uncleaved intact strand. By incorporation of a 
fluorophore and quencher adjacent to each other but on opposite strands, the catalytic beacon transforms 
metal ion-dependent catalysis into a metal ion-dependent turn-on fluorescent signal (Figure 1.5.b).  The 
major advantage of this system is that the generality of the in vitro selection protocol is then carried over 
to sensor design, or in other words, that sensors for metal ions can be effectively obtained through a 
combinatorial selection process.51,52,54 
 
Figure 1.5. (a) General form of catalytic beacon design, with terminology labeled. F, Q1, and Q2 represent fluorophore and 
quenchers 1 and 2. (b) Mechanism of fluorescence response. After cleavage of RNA base (rA, in red) substrate arms dehybridize, 
isolating fluorophore from quenchers and resulting in fluorescence turn-on signal. 
 
1.6 Thesis goals and outlook 
 
 DNAzyme sensors are interesting and useful sensing scaffolds that have been applied in many 
environmental applications with great success.51 However, although DNAzymes would have significant 
advantages in cellular sensing applications, most of this potential has thus far been unreached. This thesis 
looks to explore the application of DNAzymes for cellular sensing of metal ions. 
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 One barrier in the use of DNAyzmes within the cells is its instability under cellular conditions and 
the possibility of substrate cleavage before being targeted to the cellular components of interest. In 
chapter two, I describe my efforts in overcoming this barrier, and a method for enabling cell sensing using 
photoactivation. I describe the design and implementation of a photocaging strategy for enabling the 
general usage of DNAzymes as cellular sensors.  
 Another difficulty on the way of using DNAzymes as cellular metal ion sensors is that the process of 
introducing the DNAzyme into cells is not consistent. Hence, different cells can have different numbers 
of the sensor which in turn will effect the intensity of the output signal. To address this issue, in chapter 
three I describe work on a modified ratiometric sensor allowing quantitative sensing. I demonstrated a 
modification of the classic catalytic beacon design that allows for ratiometric sensing, which can enable 
quantitative detection within cells.  
 In chapter four, I describe a refinement of the photocaging strategy involving upconversion 
nanoparticles to enable uncaging of a DNAzyme by long-wavelength irradiation. This chapter 
demonstrates a proof of concept method that potentially enables the future use of DNAzyme sensor 
technology in more complex biological models. 
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Chapter 2: 
 
Development of a caged DNAzyme for cellular metal ion sensing 
 
* Portions of this chapter have been previously published in Angew. Chem. as “Photocaged DNAzymes as 
a General Method for Sensing Metal Ions in Living Cells” (Hwang K., Wu P., Kim T., Lei L., Tian S., 
Wang Y., Lu Y.). Wu P. assisted with cell culture, Tian S. assisted in caged nucleotide synthesis and 
characterization, and Kim T. and Lei L. provided assistance in confocal microscopy. 
 
2.1 Introduction 
 
 The widespread applicability of DNAzymes as metal ion sensors for environmental applications led 
to interest in potentially applying them as cellular sensors. However, for many years the majority of work 
using DNAzymes was limited purely to detection of environmental samples such as water or soil samples, 
with very few demonstrating detection in any biological context, whether tissue, cells, or even growth 
media.1,2 The potential impact of being able to convert as-selected DNAzymes into cellular sensors is that 
it might enable researchers to sidestep the current difficult process of rationally designing the cellular 
sensor to fit all necessary properties for cellular application.3  
 Previously our group demonstrated a method for conjugating DNAzymes to a gold nanoparticle 
carrier (DNAzyme-AuNP), which enabled moderate serum stability and the ability to deliver the 
DNAzyme-AuNP conjugates to the lysosomes of HeLa cells.4 While this approach demonstrated efficient 
cell uptake and retention of the UO22+-specific activity of the 39E DNAzyme, certain limitations 
remained. The first was the adventitious localization of DNAzyme-AuNP conjugates to the lysosome due 
to the endocytic mechanism of uptake. While the 39E DNAzyme is most active under acidic conditions 
such as those within late endosomes or the lysosome, the majority of DNAzymes obtained so far are not 
optimized for activity at low pH. Moreover, being able to sense the metal ions in other compartments is of 
interest for many applications. The second limitation is that the DNAzyme is always active. Since many 
of the other metal ions of interest may be present within the extracellular environment, the DNAzyme 
sensor might react with those metal ions and report on the presence of metals in the extracellular 
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environment and not intracellular metal ions as originally intended. Finally, although the AuNP 
conjugation strategy afforded moderate serum stability, another major concern would be the presence of 
intra- or extracellular nucleases that might be able to degrade the RNA base incorporated in the DNA-
RNA chimeric substrate strand.  
 The above-mentioned issues are not restricted to DNAzymes only and have been observed for many 
types of small-molecule or protein-based signals or sensors as well.5-9 One common strategy to address 
undesired off-target activity of the molecule in question is to inactivate it until it reaches the desired 
location in the cell. There are several types of “caging” strategies to achieve this goal. Most frequently 
caging is achieved through attachment of a protecting group to part of the sensor that is known to be 
critical for the sensor’s activity.9,10 Ideally, this attachment is labile and can later be removed, or 
“decaged.” This decaging process can be induced by a change in pH, irradiation of light, or the action of 
an enzyme within the cell, among many other choices.10-15  
 Light-activated caging groups are of particular interest as they can provide spatiotemporal control 
over the sensor.9 Since activation by light is independent of the cellular location of the sensor, it can be 
generalized to all types of sensor regardless of the compartment it is ultimately transported to. Several 
reports are available of the design of light-activated caged compounds with significant success in 
providing insight or control over multiple cellular processes.10,16,17 Although there have been reports of 
caging strategies to control the activity of DNAzymes,18-22 the applicability of such techniques towards 
DNAzymes is limited as they often do not address both the issue of substrate RNA stability and the issue 
of controlling DNAzyme activity at the same time, which may explain why no other caged DNAzyme 
strategy had previously successfully demonstrated control over DNAzyme activity within a biological 
context. 
 In this chapter I present a strategy for caging DNAzymes with a photolabile group enabling the 
protection and light-controlled activation of a DNAzyme sensor. I also demonstrate that this method can 
be generalized well to other DNAzymes, and places no restriction on choice of DNA delivery method.  
 
2.2 Materials and methods 
 
2.2.1 Synthesis of 5’-O-(4,4’-dimethoxytrityl)-2’-O-(2-nitrobenzyl)-N6-benzoyladenosine 3’-O-(2-
cyanoethyl-N,N-diisopropylamino) phosphoramidite 
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 The synthesis of the caged adenosine phosphoramidite was carried out following an established 
protocol23 and characterized by ESI-MS and 1H-NMR.  Mass spectra of the compounds were acquired 
using a Waters Quattro II spectrometer operating in positive-ion mode. Samples were injected into a 50 
µL/min flow of 100% CH3CN as mobile phase and integrated over the first minute of detection. 
 The mass spectra were collected from 200-2000 m/z. 1H-NMR spectra were carried out on a U400 FT-
NMR instrument. All reactions carried out under inert atmosphere unless otherwise noted. 4,4’-
dimethoxytrityl chloride was obtained from Acros Organics (Geel, Belgium) and used as received. DMF, 
THF, and hexanes were distilled before use; pyridine was dried over molecular sieves. All other 
compounds used during synthesis were obtained from Sigma-Aldrich (St. Louis, MO) and used as 
received. 
 
2.2.2 Oligonucleotide synthesis 
 Oligonucleotides (see Table 2.1 for sequences used) were synthesized by Integrated DNA 
Technologies (Coralville, IA). Sequences were synthesized on 1 µmol scale and were obtained with 
HPLC purification, then used without further purification. To standardize stock solution concentration, 
UV-Vis measurements at 260 nm were obtained using a Hewlett-Packard 8453 spectrophotometer. 
Absorption spectra were obtained on the same instrument. 
 
Table 2.1 DNA sequences used 
Name Sequence (5’ to 3’) 
Caged substrate /56-FAM/ACT CAC TAT /iNiBenz-rA/GG AAG AGA TGG ACG TG/3-
BHQ1/ 
Unmodified substrate /56-FAM/ACT CAC TAT rAGG AAG AGA TGG ACG TG/3-BHQ1/ 
Active 8-17E /5ThioMC6-D/CAC GTC CAT CTC TTC TCC GAG CCG GTC GAA ATA GTG 
AGT/3Dab/ 
Inactive 8-17E /5ThioMC6-D/CAC GTC CAT CTC TTC TCC GGC CCG GTC GAA ATA GTG 
AGT/3Dab/ 
GR-5E /5ThioMC6-D/CAC GTC CAT CTC TGA AGT AGC GCC GCC GTA TAG TGA 
GT/3Dab/ 
 
All sequences were obtained from IDT (Coralville, IA) and use the following notation: 
/iNiBenz-rA/ = internal 2’-nitrobenzyl-caged adenosine (described above) 
/56-FAM/ = Fluorescein 
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/3-BHQ1/ = Black Hole Quencher-1 
/5ThioMC6-D/ = thiol linker (used to cap 5’ end of enzyme strand) 
/3Dab/ = Dabcyl 
 
2.2.3 Fluorescence response and measurement 
 Equal concentrations of enzyme and substrate strands were added to a buffer solution (50 mM Tris, 
100 mM NaCl, pH 7.4) and heated to 80 °C for 5 minutes, then removed from heat and allowed to cool to 
room temperature to anneal.  
 Fluorescence measurements were obtained on a HORIBA Jobin Yvon FluoroMAX-P using 488 nm 
excitation and 518 nm emission. Fluorescence spectra were collected on the same instrument, from 500-
650 nm using 488 nm excitation; DNAzyme concentration used was 25 nM. To start the reaction 
Zn(NO3)2 was added to a final concentration of 50 µM while vortexing. Irradiation of the DNAzymes was 
carried out using a Spectroline hand lamp on the long-wavelength (365 nm) setting.  
 Decaging efficiency of both 8-17 and GR-5 DNAzymes were assessed using polyacrylamide gel 
electrophoresis (PAGE). DNAzyme reactions were initiated with addition of Zn2+ or Pb2+, and quenched 
at specific time points using a stop solution containing 8 M urea and 50 mM EDTA. Samples were loaded 
onto 20% polyacrylamide gels and run for 1.5-2 hours at 35 W to separate cleaved from uncleaved 
fragments. Fluorescence of the 5’-FAM tag was measured using a STORM 840 optical scanner using 450 
nm excitation.  
 
2.2.4 Measurement of decaging efficiency 
 Caged DNAzymes were annealed as before, except in PBS buffer solution. DNAzymes were diluted to 
a concentration of 2 µM in a well of a 24-well plate (surface area ~200 mm2) and irradiated with 365 nm 
light from either a Spectroline hand lamp on the long-wavelength (365 nm) setting or Blak-Ray B100 365 
nm lamp. Aliquots were removed at various timepoints up to 30 minutes. Decaging efficiency was 
measured using HPLC instrumentation at the Roy J. Carver Biotechnology Center (UIUC, Urbana, IL) 
equipped with a 3.5 µm SunFire C18 column (Waters) following the following program: 0-3 min, 14%B; 
3-15 min, 14-32%B; 15-20 min, 32-60%B, 20-22 min, 60-14%B; 22-33 min, 14%B using the following 
buffers: 
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Buffer A = 1 L Millipore water + 10 mL 1 M triethylamonium acetate (TEAA) (final 10 mM TEAA) 
Buffer B = 800 mL acetonitrile + 200 mL Millipore water + 2 mL 1 M TEAA 
Flow rate 0.2 mL/min throughout. 
Decaged substrate eluted at 19.6 min, caged substrate at 20.2 min. Peaks were integrated to determine 
decaging efficiency. 
 
2.2.5 Cell culture 
 HeLa cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) media supplemented with 
10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 µg/mL streptomycin solution (Cell Media 
Facility, UIUC), and were incubated at 37 °C in a humidified 5% CO2 environment. Cells were 
subcultured every 3 days, and cultures were restarted from frozen stocks after 30 passages. For 
microscopy, cells were passed into 35 mm glass-bottom petri dishes (MatTek) in growth media lacking 
penicillin/streptomycin and grown to 70-90% confluence before imaging. 
 
2.2.6 Long-term stability 
 Caged and unmodified DNAzymes were annealed in buffer by heating to 80 °C for 5 minutes and 
cooling to room temperature. Reactions were initiated by adding annealed 8-17 DNAzyme into a solution 
containing 50 µM Zn2+ or containing 80% human serum, and terminated at specific time points by adding 
aliquots into equal volumes of a stop solution containing 8 M urea and 50 mM EDTA. Extent of 
degradation was measured using PAGE, as before. 
 
2.2.7 Imaging 
 Cells grown in glass-bottom plates were transfected using Lipofectamine 2000 reagent (Invitrogen) 
using a modification of manufacturer’s protocols. Caged active or inactive DNAzymes were annealed by 
heating to 80 °C for 5 minutes and cooling to room temperature. Lipofectamine 2000 (5 µL) and annealed 
DNAzymes (1 nmol) were incubated separately in Opti-MEM media (Invitrogen) for 5 minutes, then 
combined and allowed to incubate for an additional 25 minutes. The prepared DNAzyme-Lipofectamine 
mixture was added to HeLa cells and allowed to incubate for 11 hours. Cells were also stained with 
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Hoechst 33258 (Sigma) at a final concentration of 2.5 ng/mL for 30 minutes. After incubation, cells were 
washed several times with PBS and covered with DMEM without FBS or antibiotics.  
 Images were obtained using a Zeiss LSM 710 NLO confocal microscope at 40x magnification 
equipped with a Mai-Tai Ti-Sapphire laser, using the ZEN software suite (Zeiss). Fluorescence emission 
was measured over a 500-550 nm range, with excitation at 488 nm, respectively. The pinhole and gain 
settings were kept constant throughout the whole imaging process. 
 Cells were irradiated at 365 nm with a Spectroline hand lamp while on the microscope stage. 50 µM 
zinc was added afterwards, also on the microscope stage, as the citrate salt. Individual cells showing 
response were chosen for further analysis. Quantification was carried out with the ImageJ software (NIH, 
Bethesda, MD, USA) and is represented as fold-change relative to starting fluorescence level. 
 To analyze subcellular localization, another set of images was obtained on a Nikon eclipse microscope 
using MetaFluor 6.2 and MetaMorph software (Universal Imaging) with a 420DF20 excitation filter, a 
450DRLP dichroic mirror, and two emission filters controlled by a filter changer (475DF40 for ECFP and 
535DF25 for YPet). The microscope was equipped with an environmental chamber that is temperature 
controlled at 37 °C and contains humidified 5% CO2 air. Cells transfected with caged active or caged 
inactive DNAzymes as before were imaged every 30 seconds using YFP filter settings (495 nm 
excitation/535 nm emission). Delivered DNAzymes were decaged using 340 nm irradiation (using a 
Fura2 excitation filter) at maximum light intensity for 5 seconds, then regularly imaged for 5 minutes. 
Zinc was added on the microscope stage to a final concentration of 50 µM as the pyrithione salt and 
fluorescence monitored for an additional 10 minutes. Cellular regions of interest were defined in 
MetaMorph within the nucleus (as determined by colocalization with Hoechst 33258 staining) and within 
the cytoplasm. Quantification was carried out with MetaMorph and is represented as fold-change relative 
to starting fluorescence level. 
 
2.3 Results and discussion 
 
2.3.1 Catalytic beacon and design of the photoactivation system 
 Based on previous work using RNA-cleaving DNAzymes, the basic design of the catalytic beacon 
sensor is shown in Figure 2.1. In this scheme, the enzyme strand (containing the DNAzyme catalytic 
core) and substrate strand (containing a single RNA base) are represented as black lines. In the absence of 
the specific metal ion cofactor, the two strands remain hybridized at both binding regions (binding arms) 
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by normal Watson-Crick base pairing; the melting temperature for enzyme and substrate hybridization is 
above the appropriate working temperature for the application of interest (for environmental detection 
applications, typically ~ 25 °C). While hybridized, the fluorophore on the substrate strand and a quencher 
moiety on the enzyme strand are in close proximity and the sensor fluorescence is thus suppressed. 
However, in the presence of the metal ion cofactor, the RNA base in the substrate strand is cleaved. After 
cleavage, the substrate strand’s binding arms are unable to remain hybridized due to the lowered melting 
temperature of each individual arm. As a result, the fragments dehybridize, spatially separating the 
fluorophore and quencher and producing a turn-on fluorescent signal.  
 
Figure 2.1. Schematic showing catalytic beacon photocaging strategy. The 2’ hydroxyl is modified with a protecting group which 
can be removed with light to restore the native 2’-OH functionality critical for metal-dependent activity. 
 
 The strategy for photoactivation of the DNAzyme sensor was focused on the 2'-hydroxyl moiety at 
the RNA cleavage site. This functional group is known to be critical for DNAzyme activity, and removal 
of this group (by substitution with a 2'-H moiety, as in the RNA-to-DNA substitution) is known to abolish 
DNAzyme activity. It is also known that modifications of the 2'-hydroxyl group such as the 2'-methoxy or 
2'-fluoro groups are commonly used to stabilize RNA for biological delivery (for RNAi or gene therapy 
applications). Consequently I rationalized that controllable modification at this location might enable 
control over DNAzyme activity.  
 The other major component necessary for this strategy was the choice of an appropriate controllable 
functionality. Light-removable protecting groups have been previously used for the activation of proteins, 
organic compounds, and oligonucleotides.9,12,14,16 They have also been used for controlling the activity of 
DNAzymes.18-22 However, previously published methods for DNAzyme photoactivation are unable to 
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simultaneously control both activity of the DNAzyme and stability of the substrate strand, which is 
critical for cellular application of DNAzymes as metal ion sensors. 
 
2.3.2 Synthetic characterization 
 The synthesis of the caged adenosine phosphoramidite was carried out following an established 
protocol23 and characterized by ESI-MS and 1H-NMR. The synthetic route is shown in Figure 2.2.  
 
 
Figure 2.2. Synthetic strategy for oNB-caged adenosine phosphoramidite. Synthetic scheme adapted from Ref. 23.23 
 
 Synthesis of each intermediate product was confirmed by ESI-MS (Figure 2.3) and 1H NMR spectra 
were in agreement with previously published values. Mass spectral analysis indicated the presence of 
fragmentation products at [M-135]+ corresponding to loss of nitrobenzyl group, and in the case of the 
final product peaks at [M-83]+ and [M-406]+ corresponding to hydrolysis of the N(iPr)2 acid and 
simultaneous loss of N(iPr)2 and dimethoxytrityl groups, respectively. 
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Figure 2.3. Characterization of (a) 2’-O-(2-nitrobenzyl)-N6-benzoyladenosine, expected mass: 507.1628; (b) 5’-O-(4,4’-
dimethoxytrityl)-2’-O-(2-nitrobenzyl)-N6-benzoyladenosine, expected mass: 809.29347; (c) 5’-O-(4,4’-dimethoxytrityl)-2’-O-(2-
nitrobenzyl)-N6-benzoyladenosine 3’-O-(2-cyanoethyl-N,N-diisopropylamino) phosphoramidite, expected mass: 1009.4013 
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2.3.3 Characterization of sensor properties 
 After synthesis of the phosphoramidite, the 2'-nitrobenzyl-functionalized adenosine base was 
incorporated in place of the riboadenosine base of a standard DNAzyme substrate strand by standard 
solid-phase oligonucleotide synthesis (Integrated DNA Technologies, Coralville, IA). DNA sequences 
used are found in Table 2.1. Both caged and decaged substrate strands were assessed by UV-Vis and 
fluorescence (in the case of the FAM-labeled strands) spectroscopy. (Figure 2.4) Although it is not 
possible to resolve the photoremovable nitrobenzyl group by UV-Vis due to the large UV absorbance 
peak of DNA (nitrobenzyl ε = 3700 mol-1cm-1, versus ~300000 for substrate strand alone23), an increase in 
mass is observed by MALDI-MS, indicating successful incorporation of the nitrobenzyl moiety. The 
fluorescence spectrum of a FAM-labeled caged substrate shows no change in the expected fluorescence 
properties of the attached dye. 
 
 
Figure 2.4. (left) UV-Vis absorbance and (right) fluorescence spectra of caged substrate 
 
 The performance of the photocaged DNAzyme was first assessed in a buffer under physiological 
conditions. The substrate strand containing either caged adenosine or native adenosine was annealed to 
the enzyme strand. The DNAzyme reaction was initiated with the addition of 50 µM Zn2+. In the absence 
of 365 nm light, the fluorescent signal increased rapidly only in the case of the unmodified substrate 
containing the native adenosine (Figure 2.5), similar to those observed previously. In contrast, when the 
substrate strand containing the caged adenosine was used, no increase in fluorescent signal was observed, 
indicating complete inhibition of DNAzyme activity.  
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Figure 2.5. Zinc response of caged (black) and decaged (red) sequences to 50 µM Zn2+ 
 
 To confirm that activity was due to the Zn2+-specific catalysis of the DNAzyme, an inactive 
sequence in which an AG dinucleotide sequence within the predicted loop region of the 8-17 DNAzyme 
is mutated to GC was also tested under the same conditions. Compared to the active enzyme sequence, no 
fluorescent response is observed after Zn2+ addition, indicating a lack of nonspecific Zn2+-induced activity 
(Figure 2.6). 
 
 
Figure 2.6. Zinc response of active (black) and inactive (blue) 8-17 DNAzyme sequences to 50 µM Zn2+ 
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 To test whether the protective effect of the 2’-O-nitrobenzyl PG could be reversed with light 
activation, we used both a portable hand lamp (Spectroline, 365 nm) and a Blak-Ray B100 365 nm lamp 
to irradiate samples of the caged 8-17 DNAzyme for different amount of time. While no fluorescent 
signal increase was observed in the absence of light, the fluorescent signal showed an increase with time 
after addition of metal ions (Figure 2.7). Longer exposure to 365 nm light led to greater increase in 
fluorescent signal. (Figure 2.7). These results strongly suggest that the DNAzyme activity can be restored 
after light activation: the longer the exposure to light, the more active DNAzyme was uncovered and thus 
more fluorescent signal increase could be observed.  
 
 
Figure 2.7. Zinc response of caged DNAzyme after 365 nm irradiation for indicated times (Spectroline hand lamp) 
 
 The same conclusion can be drawn from the results of polyacrylamide gel electrophoresis (PAGE, 
Figure 2.8). 
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Figure 2.8. 365 nm-induced decaging of caged DNAzyme assessed by polyacrylamide gel electrophoresis.  
 The activity assays above are an indirect measure of DNAzyme decaging. HPLC separation of caged 
DNAzyme substrate photoproducts was carried out in order to directly assess the rate of decaging using 
different light sources (Figure 2.9). A Blak-Ray B100 and Spectroline hand lamp were tested and results 
were in agreement with the results of previous indirect methods. 
 
 
Figure 2.9. UV decaging efficiency profile using different light sources.  
 For biological applications, the stability of the 2'-protecting group is paramount. To test the stability of 
caged DNAzymes, substrates containing either caged or native adenosine were annealed to the DNAzyme 
strand and incubated in either buffer containing 50 µM Zn2+ or 80% human serum for extended periods of 
time. PAGE analysis revealed that the substrate containing the native adenosine was cleaved in <1 hour 
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under both conditions, but little cleavage was observed even at times up to 7 days in the presence of 50 
µM Zn2+, or 2 days in the presence of human serum (Figure 2.10).  
 
Figure 2.10. (a) Long-term stability of caged (black) and unmodified (red) 8-17 DNAzymes in presence of 50 µM Zn2+ (b) Long-
term stability of caged (black) and unmodified (red) 8-17 DNAzymes in 80% human serum. 
 
2.3.4 Cell delivery and activation 
 Having demonstrated that the caged DNAzymes are stable, we then proceeded to use the caged 
DNAzymes for sensing metal ions within cultured HeLa cells, using the Zn2+--responsive 8-17 DNAzyme 
as our model system. Zinc is present in both cells and growth media, thus the cell-delivery process itself 
poses a major challenge because the presence of endogenous Zn2+ can promote DNAzyme-based cleavage 
of the substrate strand before the DNAzyme can be delivered to the interior of the cells, in the absence of 
a protection strategy. The 8-17 DNAzyme containing the caged adenosine was delivered to HeLa cells via 
Lipofectamine 2000 following a modification of manufacturer’s protocols. Briefly, enzyme and caged 
substrate strands were heated to 80 °C and allowed to anneal. Lipofectamine 2000 (5 µL) and annealed 
DNAzymes (1 nmol) were incubated separately in Opti-MEM media (Invitrogen) for 5 minutes, then 
combined and allowed to incubate for an additional 25 minutes. The prepared DNAzyme-Lipofectamine 
mixture was added to HeLa cells and allowed to incubate for several hours. Confocal microscopy images 
of the cells transfected with DNAzyme (Figure 2.11) showed that the fluorescent DNAzyme was 
delivered inside the cells, in a diffuse staining pattern mainly localized in the nucleus (determined by 
colocalization with Hoechst stain). This distribution pattern is in agreement with previous reports 
demonstrating nuclear accumulation of DNA delivered via cationic liposomes (Lipofectamine PLUS).24 
To localize the DNAzyme probe into other organelles, alternative delivery methods can be used, such as 
the use of gold nanoparticles for lysosomal distribution.4  
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Figure 2.11. (a) HeLa cells transfected with caged active or caged inactive 8-17 DNAzyme (0.5 µM) for 11 hr, then irradiated for 
30 m at 365 nm (Spectroline hand lamp), followed by addition of 50 µM Zn citrate. DIC shows cell morphology, with Hoechst 
33258 stain overlay. Scale bar = 20 µm. (b) Normalized fluorescence intensity of cells shown in part (a). 
 
 Upon irradiation with a 365 nm lamp, followed by Zn2+-citrate addition, an increase in fluorescence 
intensity was observed with time (Figure 2.11b). To confirm that the observed increase in fluorescence 
was caused by DNAzyme activity and not nonspecific cleavage by other cellular components, we again 
used the inactive DNAzyme sequence previously demonstrated to lack Zn2+-specific activity.25 Within 
cells, the inactive DNAzyme showed no significant increase in fluorescence over 45 minutes (Figure 
2.11), confirming that the observed signal is related to DNAzyme-specific Zn2+ activity. Together, these 
results strongly indicate that the caged DNAzyme can be used to detect and image metal ions in living 
cells. 
 
2.3.5. Subcellular localization 
 I investigated whether the DNAzyme delivery method used here (Lipofectamine) would lead to 
adventitious subcellular localization and whether functionality was retained throughout the cell. Using 
another confocal microscope setup, HeLa cells transfected with DNAzymes for 24h were tracked 
regularly for 15 minutes, including brief decaging at 340 nm and for 10 minutes after Zn2+ addition as the 
pyrithione salt. A diffuse localization of fluorescence was observed within the cell, with higher intensity 
in nuclear regions (as determined by colocalization with Hoechst 33258 staining) (Figure 2.12.a). This is 
in agreement with other studies on the subcellular fate of intracellularly introduced DNAzymes. A 
fluorescence turn-on ratio of approximately 1.2 was consistently observed in both nuclear and 
cytoplasmic regions, and was not observed in cells transfected with inactive caged DNAzymes (Figure 
2.12.b). 
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Figure 2.12. Organelle-specific timecourses. (a) Images of HeLa cells transfected for 18 hr. with 0.125 nmol caged active or 
caged inactive DNAzymes. DIC shows cellular structure, FITC shows initial fluorescence, “+UV” fluorescence 5 minutes after 
decaging at 340 nm, and “+Zn” 10 minutes after subsequent addition of 50 µM zinc as pyrithione salt. (b) Nuclear and 
cytoplasmic ROIs of cells transfected with caged active or caged inactive DNAzymes were defined and normalized fluorescence 
within the ROI plotted. Red wedges indicate UV irradiation and Zn2+ addition, in order. 
 
2.3.6 Generalizability 
 After demonstrating the use of 8-17 DNAzyme for cellular sensing and imaging of Zn2+, I 
investigated whether such a method could be applied generally to other DNAzymes for detection of their 
respective target metal ions as well. Since the first discovery of DNAzymes in 1994 using in vitro 
selection, many DNAzymes have been obtained using similar selection methods. As a result, the majority 
of currently identified DNAzymes share a similar secondary structure consisting of two double stranded 
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DNA binding arms flanking the cleavage site. More interestingly, the sequence identity of the two 
binding arms are not conserved, as long as they can form Watson-Crick base pairs with the chosen 
substrate. The metal ion selectivity of DNAzymes comes from the sequence identity of the loop in the 
enzyme strand.  As a result, the exact substrate sequence that can be recognized by a DNAzyme can be 
arbitrarily chosen. This feature also allows multiple DNAzymes to recognize the same substrate sequence 
(Figure 2.13.a-b). An attractive advantage of our photocaging strategy is that we can use the same caged 
substrate strand to achieve sensing of different metal ions by using different enzyme strands. To 
demonstrate this advantage, we synthesized a DNAzyme sequence that can hybridize to the same caged 
substrate strand as the 8-17 DNAzyme, but contains the catalytic loop of the GR-5 DNAzyme, (the first 
DNAzyme, obtained in 1994), which has significant activity in the presence of Pb2+ but not with any other 
metal ions.26 As shown in Figure 2.13.c-d, the caged GR-5 DNAzyme showed little cleavage activity in 
the absence of light activation, but increasing dose-dependent increase of DNAzyme activity upon light 
activation. 
 
Figure 2.13. Generalizability of caging strategy. (a) Schematic showing hybridization of different DNAzymes (a: 8-17 and b: 
GR-5) to the same caged substrate strand. Caged and decaged (c) 8-17 and (d) GR-5 activity in presence of Zn2+ (8-17, 500 µM) 
or Pb2+ (GR-5, 2 µM). 
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2.4 Summary and conclusions 
 
 In conclusion, I have demonstrated a general and effective strategy for protecting the substrate of a 
DNAzyme sensor, enabling its delivery into cells without being cleaved during the process, and allowing 
it to be used as a cellular metal ion sensor upon photoactivation. This strategy provides enhanced stability 
(up to multiple days in serum) and allows temporal control over DNAzyme activity. As the only 
modification to the original DNAzyme is on the substrate strand, one can replace the enzyme strand 
without needing to re-optimize for each new substrate sequence, greatly improving the generalizability of 
this protection strategy. Furthermore, the enhanced stability of the caged DNAzyme does not require the 
use of a specific nanomaterial vehicle as a delivery agent, further demonstrating the wider accessibility of 
this protection approach. This work will greatly expand the applicability of DNAzymes as versatile 
biosensors and will improve the field of metal ion sensing. 
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Chapter 3: 
 
Ratiometric sensing for quantitative detection of cellular metal ions 
 
3.1 Introduction 
 
 Although many cellular sensors have been developed for the detection of labile metal ions, the 
majority of those reported are intensity-based sensors.1-4 While these sensors can have excellent dynamic 
range (especially turn-on fluorescent sensors) and have been widely used for the study of cellular metal 
ions, the use of a one-dimensional intensity-based readout can provide only qualitative data.2 A major 
complicating factor is that cell uptake of sensors cannot be expected to be consistent from one cell to 
another, or potentially even in different locations within the same cell. As a result, any observed increase 
in fluorescence from one cell to another may result from either an increased concentration of the target 
metal or from uneven loading of the sensor. This limitation is even more pronounced when cell uptake 
involves active processes, as is the case with DNAzyme delivery.5-7  
 In order to obtain quantifiable results with sensors, a common method has been the development of 
ratiometric sensors.2 The fundamental concept behind a ratiometric sensor is the use of a parameter that 
remains invariant with sensor concentration to correct for the actual concentration of the sensor. This can 
be obtained through multiple methods. The first is the direct incorporation of an additional invariant 
signal (an internal standard). One such example is demonstrated below (Figure 3.1). This example 
consists of two components – one is a target-responsive fluorophore (responding to Zn2+), and the other a 
spectrally distinct fluorophore that is designed not to interact with the metal ion. As a result, the 
fluorescent signal from the second fluorophore does not vary with variation in the analyte concentration, 
which provides a signal that is directly proportional to the total sensor concentration. 
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Figure 3.1. An example of a ratiometric sensor (Coumazin-1) based on incorporation of an internal standard. The top portion of 
the molecule (fluorescein derivative) is a zinc-responsive fluorophore. The bottom portion of the molecule is a coumarin moiety 
that is zinc-unresponsive. Figure originally from Ref. 8.8 
 
 The other common strategy that is applied to sensors is the use of Fluorescence Resonance Energy 
Transfer (FRET).9 FRET is the most common method used for ratiometric cellular sensing with protein-
based sensors due to the availability of a spectrum of fluorescent proteins.10-12 FRET is the observed 
property that energy transfer from one dye (termed the FRET donor) to another (termed the FRET 
acceptor) can occur in a distance-dependent manner (Figure 3.2).9 This provides information about the 
distance between the donor and acceptor molecule. In FRET-based sensing, the sensor is designed such 
that a conformational change occurs after target recognition, changing the distance between FRET donor 
and acceptor and leading to a change in FRET efficiency.13 As a result, either the FRET efficiency or a 
simpler FRET ratio (ratio of acceptor fluorescence to donor fluorescence with consistent excitation of the 
donor only) can be calculated and used to correct for variations in sensor concentration.9,14  
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Figure 3.2. Schematic showing basic principle behind FRET-based sensing. Proximity of a donor and acceptor 
fluorophore enables energy transfer between the two, reporting on the relative distance of the two molecules. Figure 
adapted from Ref. 15.15  
 
 The catalytic beacon sensor that has been demonstrated for cellular detection is an intensity-based 
sensor, and thus all reported cellular applications are qualitative.16-18 One of the major advantages of the 
use of the DNAyzme scaffold is the ease of incorporating modifications during the process of DNA 
synthesis.19 As a result, it is relatively simple to envision methods for incorporation of an internal 
standard fluorophore, or for use of a FRET donor/acceptor pair in place of the classic 
fluorophore/quencher design. In this chapter, I present designs for the production of a ratiometric FRET 
sensor and early tests demonstrating their function within cells. I further demonstrate a detailed analysis 
of the sensor properties of such a FRET-enabled 8-17 DNAzyme and show that the FRET response 
remains consistent over a wide range of DNAzyme and Zn2+ concentrations. Finally, I further 
demonstrate work for optimization of the standard Lipofectamine protocol in an attempt to facilitate the 
use of DNAzymes within cell culture.  
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3.2 Materials and methods 
 
3.2.1 Oligonucleotide synthesis 
 Oligonucleotides (see Table 3.1 for sequences used) were synthesized by Integrated DNA 
Technologies (Coralville, IA). Sequences were synthesized on 250 nmol or 1 µmol scale and used without 
further purification. To standardize stock solution concentration, UV-Vis measurements at 260 nm were 
obtained using a Hewlett-Packard 8453 spectrophotometer using extinction coefficients calculated from 
IDT OligoAnalyzer. Absorption spectra were obtained on the same instrument. 
 
Table 3.1 DNA sequences used 
Name Sequence (5’ to 3’) 
Design 1 substrate /56-FAM/ACT CAC TAT rAGG AAG AGA TGG ACG TG/3InvdT/ 
Design 2 substrate /56-FAM/ACT CAC TAT rAGG AAG TGA TGG ACG TG/36-TAMSp/ 
Design 3 substrate /56-FAM/ACT CAC TAT rAGG AAG /i6-TAMN/GA TGG ACG TGT/3InvdT/ 
Design 1 enzyme /5ThioMC6-D/ CAC GTC CAT CTC TTC TCC GAG CCG GTC GAA ATA GTG 
AGT/36-TAMSp/ 
Design 2, 3 enzyme CAC GTC CAT CAC TTC TCC GAG CCG GTC GAA ATA GTG AGT 
Design 4 enzyme /5Cy5/ ATA GTT TCT CCG AGC CGG TCG AAA CTT CTC TAC CTG CAA 
Design 4 substrate TTG CAG GTA GAG AAG TrAG GAA ACT AT /3Cy3Sp/ 
 
All sequences were obtained from IDT (Coralville, IA) and use the following notation: 
/56-FAM/ = 5’ fluorescein 
/5-TAMN/ = 5’ TAMRA 
/36-TAMSp/ = 3’ TAMRA 
/i6-TAMN/ = internal (thymine-linked) TAMRA base 
/3Cy3Sp/ = 3’- Cy3 
/5Cy5/ = 5’- Cy5 
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/3InvdT/ = 3’ inverted dT (to block 3’ end) 
/5ThioMC6-D/ = 5’ thiol linker (to block 5’ end) 
 
3.2.2 Fluorescence measurements (FAM/TAMRA, Designs 1-3) 
 Equal concentrations of enzyme and substrate strands were added to a buffer solution (50 mM Tris, 
100 mM NaCl, pH 7.4) and heated to 80 °C for 5 minutes, then removed from heat and allowed to cool to 
room temperature to anneal.  
 Fluorescence measurements were obtained on a HORIBA Jobin Yvon FluoroMAX-P using 488 nm 
excitation for FAM and 518 nm excitation for direct TAMRA excitation. Fluorescence spectra were 
collected on the same instrument, from 500-650 nm using 488 nm excitation; DNAzyme concentration 
used was 25 nM. To start the reaction Zn(NO3)2 was added to a final concentration of 50 µM while 
vortexing.  
 After annealing, cleavable and uncleavable DNAzymes were mixed with 20% glycerol and loaded 
onto a 16% native polyacrylamide gel (50 mM Tris/acetic acid, pH 8.0, 100 mM NaNO3), then run at a 
power of 4W at 4 °C for 10 hours. Fluorescence of the 5'-FAM tag was measured using a STORM 840 
optical scanner using 450 nm excitation. Specific bands were cut from the gel, crushed, and soaked by 
shaking for 3 h in a soaking buffer containing 100 mM total Na+ (50 mM Na-MES, pH 5.5, 50 mM 
NaNO3) and previously treated with Chelex 100 to remove divalent metal ions. DNA samples were 
recovered from the supernatant after centrifugation. 
 
3.2.3 Fluorescence measurements (Cy3/Cy5, Design 4) 
 Equal concentrations of enzyme and substrate strands were added to a buffer solution (50 mM Tris, 
100 mM NaCl, pH 7.4) and heated to 80°C for 5 minutes, then removed from heat and allowed to cool to 
room temperature to anneal. Fluorescence measurements were obtained on a HORIBA Jobin Yvon 
FluoroMAX-P using 500 nm excitation (to excite Cy3) or 590 nm excitation (to excite Cy5 directly). In 
all cases fluorescence spectra were obtained over the range 510-800 nm. For timecourse measurements 
three scans were made at 30 second intervals: 500 nm ex/564 nm em, 500 nm ex/666 nm em, and 590 nm 
ex/666 nm em, corresponding to (excitation/emission) Cy3/Cy3, Cy3/Cy5, and Cy5/Cy5. DNAzyme 
concentrations used ranged from 2 to 2000 nM. To initiate the DNAzyme reaction Zn(NO3)2 was added to 
a final concentration of 0, 6.25, 12.5, 25, 50, or 100 µM while vortexing.  
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3.2.4 Data processing and calculations (RatioA, EFRET, and curve fitting) 
 Data was processed in OriginPro9.0 (OriginLab, Massachusetts), licensed to UIUC. Individual 
contributions to the overall fluorescent spectrum from Cy3 and Cy5 were deconvoluted by scaling spectra 
taken of each dye independently, then integrated to obtain total fluorescence from each dye. EFRET was 
calculated based on the RatioA method,20,21 using reference values for absorbance of each dye. EFRET was 
calculated at each timepoint and the initial rate of change (k) of EFRET was determined by fitting to a one-
phase exponential decay function (ExpDec1). Calculated values for k and standard deviation σ were 
plotted versus added Zn2+ concentration and limit of detection was calculated based on the formula LOD 
= 3σblank. 
 
3.2.5 Cell culture 
 HeLa cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) media supplemented with 
10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 µg/mL streptomycin solution (Cell Media 
Facility, UIUC), and were incubated at 37°C in a humidified 5% CO2 environment. Cells were 
subcultured every 3 days, and cultures were restarted from frozen stocks after 30 passages. For 
microscopy, cells were passed into 35 mm glass-bottom petri dishes (MatTek) in growth media lacking 
penicillin/streptomycin and grown to 70-90% confluence before imaging. 
 
3.2.6 Flow cytometry 
 HeLa cells grown in 24-well plates were transfected using Lipofectamine 2000 reagent (Invitrogen) 
using a modification of manufacturer’s protocols. Caged active or inactive DNAzymes were annealed in 
PBS by heating to 80°C for 5 minutes and cooling to room temperature. Lipofectamine 2000 (5 µL) and 
annealed DNAzymes (1 nmol) were incubated separately in one of five types of media for 5 minutes, then 
combined and allowed to incubate together for an additional 25 minutes. The incubation media used were 
Opti-MEM (Invitrogen), PBS (Gibco), DMEM supplemented with 10% FBS, DMEM media, HEPES 
buffer (50 mM, pH 7.2, 100 mM NaCl), and Tris-Acetate buffer (50 mM, pH 7.2, 100 mM Na-acetate). 
The prepared DNAzyme-Lipofectamine mixture was added to HeLa cells and allowed to incubate for 6 
hours. Cells were washed several times with PBS, then lifted with 0.25% trypsin-EDTA, pelleted by 
centrifugation, resuspended in PBS, and analyzed on a BD LSR II flow cytometer equipped with 488 nm, 
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640 nm, and 403 nm lasers. Fluorescence of FAM was assessed using a 505 longpass dichroic mirror and 
530/30 bandpass filter set. 
 
3.2.7 Confocal microscopy 
 Cells grown in glass-bottom plates were transfected using Lipofectamine 2000 reagent (Invitrogen) 
using a modification of manufacturer’s protocols. Caged active or inactive DNAzymes were annealed by 
heating to 80°C for 5 minutes and cooling to room temperature. Lipofectamine 2000 (5 µL) and annealed 
DNAzymes (1 nmol) were incubated separately in PBS  for 5 minutes, then combined and allowed to 
incubate for an additional 25 minutes. The prepared DNAzyme-Lipofectamine mixture was added to 
HeLa cells and allowed to incubate for 11 hours. Cells were also stained with Hoechst 33258 (Sigma) at a 
final concentration of 2.5 ng/mL for 30 minutes. After incubation, cells were washed several times with 
PBS and covered with DMEM without FBS or antibiotics.  
 Images were obtained using a Zeiss LSM 710 NLO confocal microscope at 63x magnification 
equipped with a Mai-Tai Ti-Sapphire laser, using the ZEN software suite (Zeiss). Fluorescence emission 
of Cy3 and Cy5 were gated separately using an installed twin gate beam splitter and recorded 
independently using both Cy3 excitation (514 nm laser) and Cy5 excitation (564 nm laser) conditions. 
Pinhole and gain settings were kept constant throughout the whole imaging process. Activity of 
transfected DNAzymes was measured after addition of 50 µM zinc on the microscope stage, as the 
pyrithione salt.  
 Images were processed using ImageJ (NIH, Bethesda). Cellular regions of interest were selected and 
RGB values integrated using batch calculations. The FRET ratio R was calculated as the ratio of 
integrated fluorescence (at constant Cy3 excitation), R = F(Cy5)/F(Cy3). 
 
3.3 Results and discussion 
 
3.3.1 Initial design of the ratiometric sensor 
 The initial designs of the ratiometric sensor utilized the dyes FAM and TAMRA, which have been 
previously utilized as a FRET donor/acceptor pair.22 Predicted secondary structures for the DNAzyme and 
the placement of the fluorophores for three designs are shown in Figure 3.3. In design 1, FAM and 
TAMRA were placed on the 5' of the substrate strand and 3' of the enzyme strand, respectively. In design 
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2 FAM and TAMRA were placed on opposite termini of the substrate strand. In design 3, FAM was 
attached to the 5' terminus of the substrate strand and TAMRA was incorporated into the other binding 
arm by incorporation of a TAMRA-linked dT base. 
 
Figure 3.3. Designs 1, 2, and 3 for FRET-labeled constructs. Green and red circles indicate locations of FAM and TAMRA, 
respectively.  
 
3.3.2 Fluorescence properties	   
 A native PAGE gel run using uncaged FAM- and TAMRA-labeled DNAzymes (Design 1) 
demonstrated FRET qualitatively by reduction of FAM fluorescence (caused by energy transfer to 
proximal TAMRA dyes), as shown in Figure 3.4. However, despite using divalent metal-free conditions, 
significant degradation of the cleavable DNAzyme constructs was observed, and purification of the band 
corresponding to intact DNAzyme using standard protocols resulted in recovery only of fully cleaved 
substrate.  
	  	  
	   	  
Design	  1	   Design	  2	   Design	  3	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Figure 3.4. Native gel of initial DNAzyme FRET construct (Design 1). All lanes have equal FAM loading, differences in 
observed fluorescence are attributed to FRET to adjacent TAMRA dye. 
 
 Fluorescence properties of the annealed FAM-TAMRA labeled DNAzymes were measured to assess 
whether FRET occurs between the attached dyes. As shown in figure 3.5, Design 1 shows energy transfer 
from the FRET donor FAM to the FRET acceptor TAMRA, evidenced by FAM quenching. However, the 
corresponding increase in TAMRA fluorescence was very slight.  
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Figure 3.5. (black line) Initial fluorescence of Design 1 (adjacent FAM, TAMRA), and (red, green, blue lines) after subsequent 
addition of 100 µM Zn2+. Times indicated in legend. 
 
 To ensure that the TAMRA and FAM fluorophores were intact and functional, I measured the 
fluorescence of each dye independently (Figure 3.6). As demonstrated in the figure, a much higher 
TAMRA increase is expected in the concentration used for the fluorescent studies. Spectra were taken at 
timepoints of 5, 10, and 20 minutes after addition of 100 µM Zn2+ to ensure complete cleavage. This 
provided spectra showing the minimum FRET possible for each construct.  
 
Figure 3.6. Individual fluorescence scans of DNA singly modified with one dye: (a) TAMRA, (b) FAM. Concentrations of dye 
are the same as in Figure 3.5. 
 
 Design 3 (Figure 3.7) showed very similar properties to design 1; while FRET was observed due to 
FAM quenching, the increase in TAMRA fluorescence was much lower than expected. 
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Figure 3.7. Fluorescent measurements of Design 3 (internal TAMRA): (a) initial fluorescence of Design 3, in triplicate, (b) 
fluorescence after addition of 100 µM Zn2+. 
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 Design 2 showed no observable FRET or fluorescent changes upon addition of Zn2+ (Figure 3.8). 
 
Figure 3.8. Fluorescent measurements of Design 2 (full-length FAM-TAMRA): (a) initial fluorescence of Design 2, in triplicate, 
(b) Activity after addition of 100 µM Zn2+. 
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 The qualitative results shown above indicate significant changes in the fluorescence output of Design 1 
and 3 after DNAzyme cleavage. Fluorescence timecourses using Design 3 were carried out to determine 
the kinetics of this change (Figure 3.9). 
 
Figure 3.9. Example fluorescence trace of Design 3 DNAzyme taken over 10 minutes after addition of 100 µM Zn2+. Times 
shown are in seconds. 
 
 RatioA is a method for measuring the FRET efficiency EFRET quantitatively based on measurement of 
two fluorescent spectra: the fluorescence of the FRET acceptor when exciting only the FRET donor, and 
the fluorescence of the FRET acceptor when directly exciting the FRET acceptor.21 However, calculating 
FRET efficiency using RatioA is only valid when the FRET donor and acceptor are not in direct contact.20 
If too close, the formation of exciton states by collisional contact of the donor and accept alters 
fluorescence properties in a way that is difficult to predict.20 Based on the spectra shown in Figure 3.5, 
RatioA calculations would be inaccurate for Design 1 due to quenching of both dyes observed.20 While 
Design 2 and 3 did not show collisional quenching due to the much longer distance between dyes, EFRET 
was lowered due to the increased distance between donor and acceptor in these designs. The distance 
between the FAM and TAMRA dyes in Design 2 was predicted to be approximately 9 nm (25 bp) based 
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on a typical estimate of 3.5 nm per 10 base pairs for B-form DNA, or ~ 5.25 nm for Design 3 (16 bp). For 
the FAM/TAMRA FRET pair, the Förster radius R0 is reported to be 4.9-5.4 nm, leading to a calculated 
theoretical EFRET of 0.03 for Design 2 and 0.5 in Design 3.  
 However, although EFRET could not be accurately calculated in Design 1 and was predicted (and 
observed) to be extremely low in Design 2, it could be calculated for Design 3. Using reference values of 
0.8 and 0.2 for FAM and TAMRA absorbance, respectively, EFRET for the FAM/TAMRA pair was 
calculated for a series of DNAzymes at different Zn2+ concentrations over the range 6.25-100 µM. (Figure 
3.10a) The initial rate of change of EFRET was plotted against Zn2+ concentration, and a linear response 
was observed. (Figure 3.10b) Based on the standard definition of limit of detection (LOD) as three times 
the standard deviation of a blank sample (LOD = 3σblank), the limit of detection was calculated to be 0.427 
µM Zn2+. This compares favorably to reported limits of detection using the 8-17 DNAzyme for 
fluorescence detection of Zn2+ in environmental samples, which reach 0.3 ppm (4.58 µM).23 
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Figure 3.10. Sensor kinetics: Calculated EFRET versus time, limit of detection for FAM-TAMRA design 
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3.3.3 Revised design of ratiometric sensor (Cy3/Cy5) 
 Based on the results from the earlier designs, the FRET donor/acceptor pair was changed from the 
xanthene dyes FAM and TAMRA to the cyanine dyes Cy3 and Cy5. The rationale for this change was 
twofold. First, the Förster radius (the distance at which the energy transfer efficiency is 50%) for Cy3 and 
Cy5 is slightly larger than that for FAM and TAMRA, with reported distances in the range of 5.3-5.4 
nm.24-26 More importantly, Cy3 and Cy5 are reported not to demonstrate collisional quenching even when 
directly adjacent to each other,27 whereas xanthene dyes such as FAM and TAMRA are known to do so. 
As a result I investigated Design 4, which is similar to FAM/TAMRA design 1 in that Cy3 and Cy5 are 
directly adjacent and on opposite strands (Figure 3.11). 
 
Figure 3.11. Design 4 of FRET construct. Green and red circles indicate Cy3 and Cy5 fluorophores, respectively.  
 
3.3.4 Fluorescent properties of the Cy3/Cy5 design 
 The fluorescent properties of the Cy3/Cy5-functionalized DNAzyme were investigated using 
fluorescence spectroscopy as before. Fluorescence spectra were taken at a Cy3 excitation wavelength of 
500 nm and scanned over the range of 510-800 nm. While uncleaved, the maximum intensity of both Cy3 
and Cy5 were of similar magnitude, indicating significant FRET between the two dyes. After addition of 
100 µM Zn, the Cy3 peak greatly increased in intensity and Cy5 peak correspondingly decreased, 
indicating significant loss of FRET (Figure 3.12). 
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Figure 3.12. Fluorescent traces of the Cy3/Cy5 design (Design 4) 
 
3.3.5 FRET efficiency/FRET ratio calculations 
 As before, FRET efficiency was calculated using the RatioA method. Absorbance values for Cy3 and 
Cy5 at the wavelengths used are given in the following table: 
 
Table 3.2 Calculated absorbance values used for EFRET calculations. 
 Cy3 Cy5 
ε(500 nm) 30000 L/mol-cm 12500 L/mol-cm 
ε(590 nm) ~ 0 50000 L/mol-cm 
 These values are calculated based on the relative absorbance at the indicated wavelengths versus 
maximum absorbance28 and the following reference values for the maximal absorbance.29,30  
εmax(Cy5) = 250000 L/mol-cm 
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εmax(Cy3) = 150000 L/mol-cm 
RatioA is calculated by subtracting a scaled donor (Cy3) emission spectrum from the combined donor + 
acceptor (Cy3 direct, Cy5 from FRET) fluorescence emission spectrum at donor excitation (500 nm). This 
value is divided by a reference value of acceptor excited directly (590 nm). EFRET is then calculated using 
the following formula: 
 
RatioA = [εD(500) * EFRET - εA(500)]/[εA(590)]      Equation 3.1 
 
 However, using this formula, the calculated initial FRET efficiency for the Cy3 and Cy5 dyes in 
Design 4 is determined to be 1.5. This number is nonphysiological (EFRET is defined only up to a 
maximum of 1) and indicates the possible formation of excitonic states. This conclusion is supported by 
further evidence that the fluorescent properties of the Cy5 dye in the Cy3 and Cy5-labeled DNAzyme are 
altered. A timecourse was performed measuring at three specific pairs of excitation and emission at 30 
second intervals after the addition of 100 µM Zn2+. 
500 nm excitation, 564 nm emission (Cy3 excitation, Cy3 emission) 
500 nm excitation, 666 nm emission (Cy3 excitation, Cy5 emission – from FRET) 
590 nm excitation, 666 nm emission (Cy5 excitation, Cy5 emission) 
  As observed previously with measurements at Cy3 excitation only (Figure 3.12), Cy3 emission 
increases and Cy5 FRET-based emission decreases. Unexpectedly, the fluorescence of Cy5 under direct 
excitation is also increased significantly at the same time. (Figure 3.13) This suggests strongly that in 
contrast to previous reports,27 that there is alteration of the energy levels of Cy3 and Cy5 caused by their 
extreme proximity. This fact precludes calculation of EFRET through the RatioA method.20  
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Figure 3.13. Timecourse of Cy3 and Cy5 fluorescence from direct or FRET-induced fluorescence after addition of 100 µM Zn2+ 
to 500 nM 8-17 DNAzyme (Design 4). 
 
 However, many cellular applications of FRET-based sensors often do not use EFRET calculations 
directly, instead using either a direct ratio of integrated fluorescence14 or utilizing one of a number of 
bleaching strategies to deconvolute donor and acceptor fluorescence.31 I wished to determine whether the 
alteration in photophysical properties negatively affected potential quantification by use of a direct ratio 
of integrated fluorescence. By spectral deconvolution methods, I separated the individual contributions of 
Cy3 and Cy5 from the combined fluorescence spectrum. The ratio R was calculated as F(Cy5)/F(Cy3), 
and changes in R over time were fit to a standard exponential function. By repeating this measurement at 
multiple Zn2+ concentrations I obtained a plot of initial rate constant versus Zn2+ concentration (Figure 
3.14). The data in this plot corresponded nicely to a linear fit, indicating that the direct fluorescence ratio 
may work for quantification. Based on this fit, a limit of detection of 12 µM Zn2+ was obtained at a 25 nM 
concentration of DNAzyme using the formula LOD = 3σblank. 
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Figure 3.14. Plot of rate of change of E versus Zn concentration (Design 4 – Cy3/Cy5 DNAzyme). Red line indicates limit of 
detection based on definition LOD = 3σblank.  
 
3.3.6 Kinetics of 8-17 DNAzyme 
 Fluorescent time courses were taken using multiple concentrations of [Zn2+] and [DNAzyme], with the 
intent of identifying the ranges of [Zn2+] and [DNAzyme] over which the sensor property is linear and 
consistent. All experiments were carried out in triplicate, and apparent initial rate constants were 
calculated in Origin. As shown in figure 3.15, the sensor shows linearity in a wide range of Zn and 
DNAzyme concentrations. As expected, at [Zn2+] below than the limit of detection, the measured value 
for K is no longer accurate. 
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Figure 3.15. Measurement of K values for different concentrations of Zn2+ (a) and DNAzyme (b). 
	   59	  
3.3.7 Improved cellular delivery using Lipofectamine 
 A range of conditions was investigated to optimize the process of DNAzyme delivery using 
Lipofectamine 2000. Prior PAGE analysis of uncaged DNAzymes indicated significant degradation after 
treatment following the standard recommended Lipofectamine protocol, which is attributed to the 
presence of metal ions such as Zn2+ (possibly Mg2+ or Ca2+) within the standard Opti-MEM media 
formulation. However, earlier experiments indicated that cellular levels of Zn2+ inside HeLa cells were 
insufficient to cleave the 8-17 DNAzyme after UV-induced decaging, over the timescale of a normal 
imaging experiment.17 This observation also suggests that the previously reported activity of the 8-17 
DNAzyme towards common endogenous metal ions such as Mg2+ and Ca2+ is insufficient to show a false 
positive response under the cell conditions tested.17  
 The 8-17 DNAzyme motif was independently identified by several labs, in DNAzyme selections 
targeting different metal ions.32 Previous reports investigating the metal ion selectivity of the 8-17 
DNAzyme identified a pattern of metal ion-dependent activity in the order Pb2+ >>  Zn2+ >> Mg2+, with 
reported apparent Kd towards Mg2+ of 53 mM.33 The relative activity of a number of 8-17 DNAzyme 
sequences towards Mg2+ and Ca2+ was measured by Peracchi and most sequences tested showed 10 to 20-
fold higher activity towards Ca2+ than to Mg2+ (at a concentration of 3 mM of either metal ion) 
 Within a cellular environment, Mg2+ and Ca2+ are relatively common metal ions (labile cytoplasmic 
Mg2+ around ~1-5 mM34, average cytoplasmic Ca2+ concentration in the range of 100 nM – 1 µM35) 
compared to most transition metal ions, which are present in labile form at concentrations many orders of 
magnitude lower than either Mg2+ or Ca2+.36,37 As a result, nonspecific binding to Mg2+ or Ca2+ has often 
been a significant hurdle for many metal ion sensors.38 In the case of the 8-17 DNAzyme, the relatively 
low binding affinity of DNA for metal ions indicates low propensity for nonspecific activation in the 
cellular environment, albeit with a corresponding reduced sensitivity for the target transition metal ion as 
well.  
 For the 8-17 DNAzyme, it was rationalized that if a method could be identified that removed 
activating metal ions (Zn2+, Mg2+, or Ca2+) from the extracellular media during the transfection step, it 
might allow for use of an uncaged 8-17 DNAzyme construct directly within the cellular environment. 
This might simplify the application of 8-17 or similar DNAzymes in the future. 
 A range of different buffers including Opti-MEM, PBS, DMEM, HEPES, and Tris buffers were used 
in place of Opti-MEM and HeLa cells treated with uncleavable FAM-labeled DNA sequences in order to 
assess cell uptake. Cell fluorescence was measured after 6 hours by flow cytometry (Figure 3.16, Table 
3.3). 
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Figure 3.16. Flow cytometry results of DNAzyme uptake after Lipofectamine transfection using different buffers. Indicated 
region (dark red) is identical for all histograms and indicates the region of fluorescence containing less than 2% of total negative 
control cells. In all figures, the black trace indicates control untransfected cells. The other two overlaid traces in all histograms 
after the first are the results of two transfection experiments with 250 pmol DNA in the indicated buffer. 
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Table 3.3 Percentage of transfected cells with fluorescence greater than 98% of negative control 
fluorescence (defined as positive transfection). Numbers indicate results from two individual trials. Buffer 
conditions indicated are same as in Figure 3.16. 
 
 No DNA Opti-MEM PBS DMEM HEPES Tris-acetate 
% positive 
1.93% 
(defined) 
16.18%, 
25.48% 
52.35%, 
41.26% 
28.70%, 
28.48% 
0.19%, 
0.57% 
0.28%, 
0.18% 
 
 The resulting fluorescent data showed that PBS, DMEM (+ 10% FBS), and Opti-MEM were capable 
of efficient DNA delivery. These three conditions were further analyzed by confocal microscopy using 
FAM-labeled DNA strands to determine if differences in DNA localization occurred with different 
transfection buffer conditions (Figure 3.17). 
              Opti-MEM                            PBS                       DMEM w/ FBS              DMEM w/o FBS 
    
Figure 3.17. HeLa cells transfected with FAM-labeled DNA using Lipofectamine utilizing different types	  of incubation media. 
Blue channel is Hoechst 33258 for nuclear staining, green channel FAM-labeled DNA, red channel MitoTracker Red. 
 
 No significant differences in DNA localization were observed with different incubation buffers. 
Incubation in Opti-MEM displayed a punctate pattern of DNA fluorescence and occasional diffuse 
staining in the nucleus (as indicated by colocalization with Hoechst 33258 staining). This result was also 
generally observed with the other buffers that demonstrated successful transfection. 
 In order to assess whether the substitution of PBS for Opti-MEM was sufficient to deliver the 8-17 
DNAzyme in an active form, an active uncaged variant of the FRET construct DNAzyme was delivered 
using the PBS incubation protocol (Figure 3.18). Green fluorescence (Cy3 excitation and emission) was 
measured at different timepoints after addition of 50 µM Zn2+ as the pyrithione salt on the microscope 
stage.  
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Figure 3.18. Timecourse of uncaged FRET construct fluorescence in response to Zn2+. First image is overlay of DIC and 
fluorescent channels to show overall cell morphology. Remaining images are confocal fluorescent images taken at 10 minute 
intervals after addition of 50 µM Zn2+ as pyrithione salt. Green channel shows Cy3 fluorescence at Cy3 excitation; red channel 
shows Cy5 emission with direct Cy5 excitation. Blue channel is nuclear stain (Hoechst 33258), scale bar = 20 µm. 
 
 Although there was an observed diffused fluorescence within the Cy5 channel that did not seem to 
correspond to DNAzyme fluorescence (due to lack of colocalization with Cy3) the green fluorescence of 
Cy3 noticeably increased after Zn2+ addition, indicating that the 8-17 DNAzyme still retained activity 
inside cells and was thus not degraded prior to cell entry. 
 
3.3.8 Ratiometric cellular detection of metal ions  
 The Cy3/Cy5-labeled 8-17 DNAzyme was delivered to HeLa cells using the PBS Lipofectamine 
protocol developed above with an uncaged FRET construct. Cells were stained with Hoechst 33258 and 
imaged via confocal microscopy. Figure 3.19 shows images of cellular fluorescence under three 
excitation conditions: 
DIC                                     0 min                                    10 min 
20 min                                  30 min                                 40 min 
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Cy3 (Cy3 excitation, Cy3 emission) – green channel 
Cy35 (Cy3 excitation, Cy5 emission, = FRET) – red channel 
Cy5 (Cy5 excitation, Cy5 emission) – red channel 
 
	  
Figure 3.19. (left) DIC + DAPI overlay to show cell morphology. (center) Cy3 excitation (both Cy3 + Cy5 emission shown, false 
colored green and red respectively). (right) Cy5 direct excitation overlaid (Cy5 excitation/Cy5 emission). Scale bar = 20 µm. 
 
 Direct Cy5 excitation produced significant apparent nonspecific fluorescence, the pattern of which 
resembled mitochondrial staining. This observation further precluded use of the RatioA method; instead 
the observed fluorescence ratio R was calculated as R = F(Cy5)/F(Cy3). 
 Fluorescence changes were then observed after the addition of 50 µM Zn2+ as the pyrithione salt. The 
punctate fluorescent spots observed under Cy3 excitation conditions are observed to shift from orange to 
green, indicating a shift from Cy5 emission (caused by FRET) towards Cy3 emission (Figure 3.20). This 
replicates the fluorescent changes observed via bulk fluorescence spectroscopy, and indicates that the 
ratiometric sensor design is functional even within cells. 
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Figure 3.20. Timecourse showing Cy3 + Cy5 emission at Cy3 excitation settings, at 0 min, 10 min, 30 min, and 50 min after 
addition of 50 µM Zn2+ as the pyrithione salt on microscope stage. DIC (with Hoechst 33258 overlay) shows overall cell 
morphology and location of nucleus (in blue); remaining images show combined Cy3 and Cy5 fluorescence at Cy3 excitation. 
Scale bar = 20 µm. Indicated ROIs are expanded and shown directly to the right of full image in left column. 
DIC 
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 Using ImageJ the ratio of integrated Cy5 fluorescence to integrated Cy3 fluorescence at each timepoint 
above was measured. The observed FRET ratio R was observed to decrease from 3.5 initially to 1.1 over 
50 minutes after addition of Zn2+ (Figure 3.21). 
 
 
Figure 3.21. Timecourse of FRET ratio change after Zn2+ addition. FRET ratio R calculated as integrated fluorescence of Cy5 
(from Cy3-induced FRET) divided by integrated fluorescence of Cy3 within cellular regions shown in Figure 3.20. 
 
3.4 Summary and conclusions 
 
 In conclusion, I have demonstrated the redesign of the original catalytic beacon sensor to incorporate a 
FRET donor and acceptor pair. This change converts the turn-on fluorescent sensor design into one with a 
ratiometric readout, which allows cellular quantification because the ratiometric readout is unaffected by 
changes in sensor concentration. I have further investigated the concentrations of metal ion and 
DNAzyme over which the sensor response is linear and predictable, and have demonstrated that the 
ratiometric 8-17 DNAzyme functions consistently from the calculated limit of detection of 12 µM Zn2+ up 
to at least 100 µM. This sensor design should generalize towards other DNAzymes, further expanding the 
applications of the DNAzyme scaffold for cellular sensing. Finally, I demonstrate attempts to optimize 
the process of DNAzyme transfection using the commercially available transfection reagent 
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Lipofectamine, successfully demonstrating a method for transfecting an uncaged Zn2+-responsive 
DNAzyme without loss of sensor to degradation. This improved process greatly simplifies the in vitro 
application of DNAzymes. 
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Chapter 4: 
 
Synthesis of upconverting nanoparticle-caged DNAzyme conjugates for long-wavelength activation 
of DNAzymes 
 
4.1 Introduction 
 
 The photocaging method originally described in Chapter 2 is a widely generalizable strategy for the 
conversion of DNAzyme sensors obtained through in vitro selection into cellular sensors usable within 
cells.1 This approach has seen recent application in our group in the production and cellular application of 
a Na+-specific DNAzyme sensor (Figure 4.1).2 The incorporation of the photolabile nitrobenzyl moiety in 
the substrate strand of this DNAzyme enables the delivery and use of a sodium-responsive DNAzyme 
even though the conditions necessary for delivery contain sodium. The orthogonality between the 
photocaging system and delivery method suggests that any DNA delivery method applicable to 
unmodified DNA or an unmodified DNAzyme should be equally applicable to the caged DNAzyme, 
which was used to great effect in the use of a cationic helical peptide-based delivery method to deliver 
caged DNAzymes to the cytoplasm. 
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Figure 4.1. Cellular detection of Na+ using a Na+-specific DNAzyme. Cellular application of this recently-selected DNAzyme 
was made possible by the previously described photocaging strategy to inhibit premature activity caused by sodium common in 
the intra- or extracellular environment. 
 
 However, despite the demonstrated strengths of the photocaging strategy, there are a number of 
limitations introduced by its implementation. One major limitation is the requirement for UV irradiation 
(≤ 365 nm) to remove the o-nitrobenzyl photolabile protecting group.3,4 UV light is readily absorbed by 
biological media and by cells; extensive use of UV light can cause cell damage. Due to the lower 
cytotoxicity of longer-wavelength (lower energy) light, a strategy that has been investigated is the use of 
visible or near-infrared (NIR) light irradiation in place of UV.5-7 Both visible and NIR light are less toxic 
to cells than UV; furthermore, biological solutions typically have very low absorbance in the NIR region, 
allowing NIR light much greater tissue penetration.5,8 As a result the development of NIR-responsive 
compounds has been a subject of significant research interest.8 However, to date there are still very few 
reported photolabile groups that can be removed with NIR light.4,9 The best-characterized NIR-accessible 
photoremovable protecting group is the 3-nitro-2-ethyldibenzylfuran (NDBF) moiety (Figure 4.2), which 
can be efficiently removed by two-photon excitation using doubled-wavelength light of approximately 
700 nm.10 However, while this moiety has been demonstrated to have excellent decaging properties, the 
NDBF group is synthetically challenging to prepare,11,12 and to date no variant of the NDBF compound is 
commercially available. As a result, I am interested in investigating alternative methods allowing UV-free 
photoactivation of DNAzymes. 
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Figure 4.2.  Near-infrared-absorbing photolabile group 3-nitro-2-ethyldibenzylfuran (NDBF). From Ref. 11.11 
 
 A novel nanomaterial of increasing general interest is a class of lanthanide-doped metal 
nanoparticles known as “upconversion” nanoparticles (UCNPs).13,14 Due to a particular combination of 
energy states within the particle from embedded lanthanide ions, UCNPs are capable of effectively 
absorbing light in the NIR region. Furthermore, the particles have luminescent properties that can be 
tuned by modulating the particle composition, allowing for emission of higher-energy light from the 
particle.13,14 This overall process of absorption of lower-energy light, emission of higher-energy light is 
the opposite of the normal Stokes shift common to fluorophores, and is thus a property of significant 
interest as a potential method for minimizing UV usage in biological systems.13,14  
	   	  
Figure 4.3. Upconversion nanoparticle scheme and principal mechanisms leading to upconversion. Originally from Ref 13.13 
 
 UCNPs have been utilized for UV-responsive photoremovable protecting groups previously.15-18 The 
concept of local UV production by UCNP excitation has been further demonstrated to reduce the effects 
of phototoxicity within cells,19 but has not yet been applied in conjunction with caged DNAzymes. In this 
chapter I present the design and initial demonstration of an upconversion nanoparticle-DNAzyme 
complex for long-wavelength activation of a nitrobenzyl photolabile group. This allows long-wavelength 
photoactivation of a caged DNAzyme and may be useful in subsequent use of caged DNAzymes in vitro 
or in vivo. 
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4.2 Materials and methods 
 
4.2.1 Oligonucleotide synthesis 
 DNA sequences (see Table 4.1 for sequences) were obtained from Integrated DNA Technologies 
(Coralville, IA).  
 
Table 4.1 DNA sequences used 
Name Sequence (5’ to 3’) 
Caged substrate /56-FAM/ACT CAC TAT /iNiBenz-rA/GG AAG AGA TGG ACG 
TG/3-BHQ1/ 
FAM-only strand /56-FAM/ACT CAC TAT rAGG AAG AGA TGG ACG TG 
17E-12T-SH CAC GTC CAT CTC TTC TCC GAG CCG GTC GAA ATA GTG AGT 
TTT TTT TTT TTT /3ThioMC3/ 
39E-12A-amine C*A*C GTC CAT CTC TGC AGT CGG GTA GTT AAA CCG ACC 
TTC AGA CAT AGT GAG TAA AAA A*A*A/3AmMO/ 
Alkyne-12A-17E-Dabcyl /5Hexynyl/ AAA AAA AAA AAA CAC GTC CAT CTC TTC TCC 
GAG CCG GTC GAA ATA GTG AGT /3Dab/ 
 
All sequences were obtained from IDT (Coralville, IA) and use the following notation: 
/3AmMO/ = 3’- amine linker 
/3ThioMC3/ = 3’- thiol linker 
/5Hexynyl/ = 5’-alkyne linker 
/3Dab/ = 3’- Dabcyl (quencher) 
* = phosphorothioate linker 
 
4.2.2 UCNP synthesis 
 UCNPs were synthesized following standard protocol for the synthesis of β-NaYF4:Yb,Er 
nanoparticles using rare earth chlorides and oleic acid as a stabilizing ligand.20-22 UCNPs were purified by 
centrifugation after addition of ethanol, washed extensively, and redispersed in cyclohexane until further 
use. TEM was carried out at the UIUC Materials Research Laboratory (MRL). Transmission electron 
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microscopy (TEM) images were taken on a JEOL 2100 Cryo transmission electron microscope with 
accelerating voltage of 200 kV. 
 
4.2.3 Silica and DNA functionalization 
 Silica coating was carried out by addition of tetraethyl orthosilicate (TEOS) to UCNPs in water. 
Functionalization of DNA to the silica surface was carried out using two different methods: 
i. Sulfo-SMCC functionalization 
 UCNPs were amine-functionalized with (3-aminopropyl)triethoxysilane (APTES), then modified 
with Sulfo-SMCC (Thermo-Fisher) following manufacturer protocols. Thiol-functionalized DNAzyme 
sequences were deprotected right before use with TCEP, purified by 10k MWCO centrifugal filter 
(Amicon), and reacted with Sulfo-SMCC-functionalized UCNPs. 
 
ii. Azide-Alkyne coupling 
 Azide functionalization of the silica coating was carried out following a previously published 
protocol.23 Briefly, the silica-coated UCNPs were mixed with 3-azidopropyl trimethoxysilane (AzPTMS) 
in ethanol, and refluxed overnight for 10 h at 80 °C. Particles were purified by centrifugation and washed 
3x with methanol, then resuspended in PBS for DNA coupling. 
 Amine-modified DNA was mixed with 20 equivalents ADIBO-NHS in 0.5 mL dioxane and allowed 
to react overnight at room temperature. The crude reaction product was extracted 5x with an equal 
volume (0.5 mL) of dichloromethane to remove excess ADIBO and dioxane. Nitrogen gas was bubbled 
through the remaining aqueous phase to remove residual dichloromethane. For characterization of 
purified DBCO-DNAzyme, a 10k MWCO centrifugal filter (Amicon) was used to change the buffer to 
ammonium acetate, and the DNA was analyzed via MALDI-MS. 
 Strain-catalyzed click chemistry was carried out by mixing azide-functionalized UCNPs with freshly 
prepared ADIBO-modified DNAzymes in PBS. The reaction was carried out for 72 hours at room 
temperature. 
 The OliGreen DNA quantification assay was tested following manufacturer’s protocols on both 
DNA-functionalized UCNPs and on azide-functionalized UCNPs as a control. 
 DNA loading was also assessed by hybridization of a fluorescent complementary DNA sequence. A 
FAM-labeled complementary sequence was annealed to the DNA-functionalized UCNPs at 80 °C for 5 
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minutes and cooled to room temperature over 30 minutes, then purified by centrifugation 3 times. FAM 
fluorescence was measured on a HORIBA Jobin Yvon FluoroMAX-P using 490 nm excitation and 518 
nm emission, and quantified versus solutions of known FAM-DNA concentrations. 
 
4.2.4 Luminescence measurements 
 Spectra were taken on a HORIBA Jobin Yvon FluoroMAX-P equipped with a commercial CW IR 
laser (980 nm) (Thorlabs, Inc). Luminescence was scanned over the range 200-900 nm.  
 
4.2.5 Activity measurements 
 Activity of the caged 8-17 DNAzyme was carried out by hybridization of the caged substrate strand 
to UCNP-DNAzyme. 50 µM Zn2+ was added to the solution and irradiation was carried out using either a 
980 nm 1 W laser (BOB Laser Company, China) or Spectroline hand lamp set to long wavelength mode 
(365 nm). Activity was assessed by fluorescence of the supernatant at a given time point. 
 
4.3 Results and discussion 
 
4.3.1 Synthesis of UCNPs, optimization of UCNP size 
 Yb and Tm-doped NaYF4 nanoparticles were synthesized following previously published protocols. 
Improved size control was obtained by carefully controlling the rate of temperature increase during 
nucleation and synthesis. The luminescence properties of the synthesized UCNPs were measured at 980 
nm excitation. (Figure 4.4). The spectrum shows several peaks, which are in close agreement with 
previous reports of UCNPs with the same composition. Notably, there is a small emission peak within the 
range 361-365 nm, which was envisioned to enable decaging of the nitrobenzyl-caged DNAzyme (which 
is effectively decaged at wavelengths ≤ 365 nm). 
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Figure 4.4. Luminescence spectrum of uncoated UCNPs. 
 
4.3.2 Silica functionalization and characterization 
 The UCNPs were coated with silica by reaction with TEOS after removal of oleic acid, again 
following standard protocols. TEM images of the silica-coated particles (Figure 4.5) indicated successful 
and consistent silica coating of radius ~ 25 nm, covering ~ 25 nm diameter UCNPs. 
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Figure 4.5. TEM image of silica-coated UCNPs. 
 
 The luminescence spectrum of the silica-coated UCNPs was measured at 980 nm excitation (Figure 
4.6). Aside from a moderate quenching of overall luminescence, no other apparent changes to the 
emission spectra were observed. 
 
Figure 4.6. Luminescence spectra of silica-coated UCNPs excited at 980 nm. 
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 Azide-functionalization of silica-UCNP was carried out following an established protocol for 
synthesis and use of of 3-azidopropyl trimethylsilane. Azide-functionalized UCNPs were directly used for 
DNA conjugation. 
 
4.3.3 Strain-catalyzed alkyne-azide cycloaddition 
 The ADIBO-functionalized DNAzyme was synthesized by reaction of ADIBO-NHS (Figure 4.6) 
with amine-functionalized DNA. After removal of excess ADIBO-NHS and dioxane, the efficiency of 
ADIBO-functionalization of the DNAzyme was assessed by MALDI-MS. As seen in Figure 4.8, although 
the DNA peak is broad, a significant shift of the peak maximum from 18827 MW to 19310 MW is 
observed after reaction of amine-DNAzyme with ADIBO-NHS.  
 
Figure 4.7. Structure of ADIBO-NHS 
 
 
Figure 4.8. MALDI-MS of NH2-DNAzyme (expected mass 18744.4) and ADIBO-DNAzyme (expected mass 19062.8) 
 
4.3.4 DNAzyme functionalization of UCNP and DNA quantification 
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 The strain-catalyzed click reaction between ADIBO-DNAzyme and azide-functionalized UCNPs 
was carried out at room temperature for 72 hours in pH 7.4 PBS. The resulting UCNPs were purified by 
centrifugation and DNA quantified using either the OliGreen DNA quantification assay or binding of a 
complementary FAM-labeled DNA strand. 
 The OliGreen DNA quantification assay was initially used to determine the loading of DNA on 
functionalized UCNPs. However, it was observed that OliGreen shows nonspecific fluorescence turn-on 
not only with DNA, but also in the presence of azide-functionalized UCNPs alone (Figure 4.9). 
 
Figure 4.9. Nonspecific fluorescence increase of OliGreen dye (emission maximum 520 nm) in the presence of azide-
functionalized UCNPs 
 
 A complementary DNA approach was used to more accurately measure the total DNA loading. A 
fluorescently modified complementary DNA sequence was hybridized to the DNAzyme-UCNP conjugate 
and fluorescence compared to a calibration curve derived from known concentrations of FAM-DNA 
fluorescence. Based on this method, the observed total concentration of DNA was calculated to be 
approximately 0.06 nM. 
 
4.3.5 Long-wavelength decaging of a caged DNAzyme 
 The activity of the caged 8-17 DNAzyme functionalized to the UCNP surface was investigated. A 
caged 8-17 DNAzyme substrate was hybridized to the UCNP-conjugated DNAzyme and Zn2+ (100 µM) 
was added to the solution. Irradiation was performed using 365 nm or 980 nm irradiation, and supernatant 
fluorescence measured to determine the extent of DNAzyme decaging. Little fluorescence was observed 
before decaging, confirming that the caged DNAzyme remained inactive even in the presence of Zn2+. 
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Irradiation with either UV or NIR light (Figure 4.10) produced an increase in supernatant fluorescence 
caused by cleavage of the decaged DNAzyme, indicating that the DNAzyme was both still active and 
could be decaged with NIR light.  
 
Figure 4.10. Decaging of UCNP-caged DNAzymes with (a) 365 nm light or (b) 980 nm light. Fluorescent signal at 518 nm 
corresponds to cleavage of (decaged) 8-17 DNAzyme.  
 
 The degree of decaging is observed to directly correlate with total irradiation time (Figure 4.11), 
further providing that the upconversion of the nanoparticle is the cause of the observed DNAzyme 
activation. 
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Figure 4.11. Kinetics of decaging using 980 nm light (laser power 1 W) 
 
 
 
4.4 Summary and conclusions 
 
 In this chapter I demonstrated the initial design and demonstration of a strategy for avoiding the 
negative effects of UV irradiation on cells originally necessary for activating photocaged DNAzymes. 
The use of upconverting lanthanide-doped nanoparticles allows the use of near-IR excitation, which is 
more biologically compatible than UV wavelengths and may allow for future applications in vivo as well 
as in vitro. Future work will focus on demonstrating the continued usability of this design within the 
cellular environment, as well as optimization of conjugation methods to maximize decaging efficiency 
and generalizability towards other DNAzymes or nanoparticle types. 
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